Compare CORT & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | CAMT |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | Israel |
| Employees | 730 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 7.9B |
| IPO Year | 2001 | 2000 |
| Metric | CORT | CAMT |
|---|---|---|
| Price | $89.23 | $138.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $96.50 | ★ $158.55 |
| AVG Volume (30 Days) | ★ 957.9K | 462.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $14.61 |
| Revenue Next Year | $26.98 | $19.36 |
| P/E Ratio | ★ N/A | $155.63 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $75.75 |
| 52 Week High | $91.00 | $215.99 |
| Indicator | CORT | CAMT |
|---|---|---|
| Relative Strength Index (RSI) | 80.68 | 37.22 |
| Support Level | $76.41 | $141.00 |
| Resistance Level | N/A | $181.96 |
| Average True Range (ATR) | 3.76 | 11.36 |
| MACD | -0.09 | -3.65 |
| Stochastic Oscillator | 94.20 | 7.77 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Chiplets, HBM, Compound Semiconductors, Memory, CMOS Image Sensors, Power, RF and MEMS, serving the industry's IDMs, OSATs, and foundries. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.